10x Genomics, Inc. (LON:0A88)

Market Cap	1.08B
Revenue (ttm)	470.40M
Net Income (ttm)	-61.75M
Shares Out	n/a
EPS (ttm)	-0.50
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,574
Average Volume	7,082
Open	12.00
Previous Close	11.27
Day's Range	11.41 - 12.00
52-Week Range	6.95 - 18.03
Beta	n/a
RSI	40.77
Earnings Date	Oct 31, 2025

About 10x Genomics

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as ...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 2012
• Employees: 1,306
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A88

Financial Performance

In 2024, 10x Genomics's revenue was $610.79 million, a decrease of -1.28% compared to the previous year's $618.73 million. Losses were -$182.63 million, -28.41% less than in 2023.

Financial numbers in USD